×

Kraig Biocraft Laboratories Finalizes Biosafety Assessment for Vietnam

ANN ARBOR, Mich., May 24, 2016 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Kraig”), the leading developer of spider silk based fibers, today announced that it has completed the biosafety and project risk assessment for its planned operations and subsidiary in Vietnam. These documents were prepared in response to a request from the Vietnamese government to help them better understand the new technology the Company plans to introduce. The Company is now waiting for document processing by the U.S. State Department and expects to send these documents to officials in Vietnam shortly.

“Completing this detailed review for Vietnam provided us with the opportunity to dive deep into our scale up plans,” said COO Jon Rice. “By completing this process we have better prepared ourselves to begin operations in Vietnam or in any of the parallel production locations we are currently exploring.”

For the most recent edition of Kraig’s Spider Sense quarterly newsletter and to keep up with the latest news, please go to www.KraigLabs.com/newsletter

About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company, is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.

Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.

Ben Hansel, Hansel Capital, LLC (720) 288-8495 ir@KraigLabs.com

Source:Kraig Biocraft Laboratories, Inc.